In conclusion, our findings support the conclusion that hepatic IGF2 expression is a carcinogenic driver in a mouse model of aging‐related HCC by causing DNA damage and supporting hepatocyte proliferation that would allow the accumulation of somatic mutations. The gene discussed is IGF2; the disease is hepatocellular carcinoma.